Report cover image

Nigeria In-Vitro Diagnostics (IVD) Market

Publisher BlueWeave Consulting
Published Oct 09, 2025
Length 120 Pages
SKU # BLWC20706883

Description

Nigeria In-Vitro Diagnostics (IVD) Market, By Product & Services (Reagents & Kits, Instruments, Software & Services); By Technique (Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Immunodiagnostics, Hematology, Others); By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others); By End User (Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2031Nigeria In-Vitro Diagnostics (IVD) Market to Surpass USD 48 Million by 2031

Nigeria In-Vitro Diagnostics (IVD) Market is flourishing because of the increasing prevalence of infectious and chronic diseases and the rapid adoption of innovations in IVD technology, such as point-of-care (PoC) testing, molecular diagnostics, and automation.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Nigeria In-Vitro Diagnostics (IVD) Market size at USD 37.12 million in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Nigeria In-Vitro Diagnostics (IVD) Market size to expand at a steady CAGR of 3.74% reaching a value of USD 48.01 million by 2031. Increasing incidences of both communicable and non-communicable diseases are key drivers of Nigeria In-Vitro Diagnostics (IVD) Market. The number of point-of-care (PoC) tests is also rising along with the use of automation in labs and automated equipment. It, in turn, is expected to provide significant growth opportunities for the players in Nigeria In-Vitro Diagnostics (IVD) Market.

Opportunity - Automation in IVD labs

Growing adoption of automated instruments and automation in laboratories is forecast to present lucrative growth opportunities for the players in Nigeria In-Vitro Diagnostics (IVD) Market in the coming years. Automated instruments provide several benefits, such as higher performance levels, enhanced productivity, data accuracy, and meeting safety protocols. As a result, the market players are developing and launching automated instruments that offer higher efficiency and effectiveness in IVD tests. The increasing test volumes and shortage of skilled lab personnel are expected to boost automation in laboratories.

Hospitals Dominate Nigeria In-Vitro Diagnostics (IVD) Market

The increasing number of hospital facilities and their dependence on IVD for diagnosis and treatment decisions fuel the demand for in-vitro diagnostic (IVD) tests. The high rate of in-patient and out-patient treatment in hospitals due to the presence of advanced diagnostic setups further contributes to the segment growth. Hence, the hospital segment dominates Nigeria In-Vitro Diagnostics (IVD) Market by end user. Meanwhile, the point-of-care (PoC) segment is also expected to grow at a high rate over the forecast period. Other major end user segments in Nigeria In-Vitro Diagnostics (IVD) Market include standalone laboratories, and academic & medical schools.

Impact of Escalating Geopolitical Tensions on Nigeria In-Vitro Diagnostics (IVD) Market

Escalating geopolitical tensions could disrupt the growth of Nigeria In-Vitro Diagnostics (IVD) Market. For example, China is a significant exporter of medical diagnostic test equipment. Additionally, geopolitical conflicts affect supply chains, making healthcare supplies harder to get and ultimately leading to price increases that might affect the growth of Nigeria Market for In-Vitro Diagnostics (IVD).

Competitive Landscape

Nigeria In-Vitro Diagnostics (IVD) market is intensely competitive, as a number of companies are competing to gain a significant market share. Key players in the market include Abbott Laboratories, Afrigold Medicure, Becton, Dickinson and Company, bioMérieux, Danaher Corporation, Me Cure Healthcare, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Union Diagnostics and Clinical Service PLC. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and Nigeria In-Vitro Diagnostics (IVD) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Nigeria In-Vitro Diagnostics (IVD) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

120 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Nigeria In-Vitro Diagnostics (IVD) Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing Prevalence of Chronic Diseases
3.2.1.2. Innovations in IVD Technology, such as Point-Of-Care Testing, Molecular Diagnostics, and Automation
3.2.1.3. Rising Healthcare Expenditure
3.2.1.4. Growing Awareness about Early Disease Detection
3.2.2. Restraints
3.2.2.1. Unfavorable Reimbursement Scenario
3.2.2.2. High Cost of Development
3.2.2.3. Stringent Regulatory Environment
3.2.3. Opportunities
3.2.3.1. Emerging Technologies such as Liquid Biopsy, Digital Pathology, and Microfluidics
3.2.3.2. Increasing Adoption of Personalized Medicine
3.2.3.3. Growing Demand for Rapid and Accessible Diagnostic Solutions
3.2.4. Challenges
3.2.4.1. Shortage of Skilled Professionals in the IVD Industry
3.2.4.2. Increasing Concerns about Data Privacy and Security
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Nigeria In-Vitro Diagnostics (IVD) Market: Marketing Strategies
5. Nigeria In-Vitro Diagnostics (IVD) Market: Pricing Analysis
6. Nigeria In-Vitro Diagnostics (IVD) Market Overview
6.1. Market Size & Forecast, 2019–2031
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product and Services
6.2.1.1. Reagents & Kits
6.2.1.2. Instruments
6.2.1.3. Software & Services
6.2.2. By Technique
6.2.2.1. Molecular Diagnostics
6.2.2.2. Tissue Diagnostics
6.2.2.3. Clinical Chemistry
6.2.2.4. Immunodiagnostics
6.2.2.5. Hematology
6.2.2.6. Others
6.2.3. By Application
6.2.3.1. Infectious Diseases
6.2.3.2. Cancer
6.2.3.3. Cardiac Diseases
6.2.3.4. Immune System Disorders
6.2.3.5. Nephrological Diseases
6.2.3.6. Gastrointestinal Diseases
6.2.3.7. Others
6.2.4. By End User
6.2.4.1. Standalone Laboratories
6.2.4.2. Hospitals
6.2.4.3. Academic and Medical Schools
6.2.4.4. Point of Care
6.2.4.5. Others
7. Competitive Landscape
7.1. List of Key Players and Their Products
7.2. Nigeria In-Vitro Diagnostics (IVD) Company Market Share Analysis, 2024
7.3. Competitive Benchmarking, By Operating Parameters
7.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
8. Impact of Escalating Geopolitical Tensions on Nigeria In-Vitro Diagnostics (IVD) Market
9. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook, SWOT Analysis)
9.1. Roche Diagnostics
9.2. Abbott Laboratories
9.3. Siemens Healthineers
9.4. Danaher Corporation
9.5. Thermo Fisher Scientific
9.6. Me Cure Healthcare
9.7. Afrigold Medicure
9.8. Union Diagnostics and Clinical Service PLC
9.9. bioMérieux
9.10. Becton, Dickinson and Company
9.11. Other prominent players
10. Key Strategic Recommendations
11. Research Methodology
11.1. Qualitative Research
11.1.1. Primary & Secondary Research
11.2. Quantitative Research
11.3. Market Breakdown & Data Triangulation
11.3.1. Secondary Research
11.3.2. Primary Research
11.4. Breakdown of Primary Research Respondents
11.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 Nigeria In-Vitro Diagnostics (IVD) Segmentation
Figure 2 Nigeria In-Vitro Diagnostics (IVD) Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 Nigeria In-Vitro Diagnostics (IVD) Market Size, By Value (USD Million), 2019–2031
Figure 5 Nigeria In-Vitro Diagnostics (IVD) Market Share, By Product and Services, By Value (USD Million), 2019–2031
Figure 6 Nigeria In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value (USD Million), 2019–2031
Figure 7 Nigeria In-Vitro Diagnostics (IVD) Market Share, By Application, By Value (USD Million), 2019–2031
Figure 8 Nigeria In-Vitro Diagnostics (IVD) Market Share, By End User, By Value (USD Million), 2019–2031
List of Tables
Table 1 Nigeria In-Vitro Diagnostics (IVD) Market Size, By Value (USD Million), 2019–2031
Table 2 Nigeria In-Vitro Diagnostics (IVD) Market Share, By Product and Services, By Value (USD Million), 2019–2031
Table 3 Nigeria In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value (USD Million), 2019–2031
Table 4 Nigeria In-Vitro Diagnostics (IVD) Market Share, By Application, By Value (USD Million), 2019–2031
Table 5 Nigeria In-Vitro Diagnostics (IVD) Market Share, By End User, By Value (USD Million), 2019–2031
Table 6 Roche Diagnostics Company Overview
Table 7 Roche Diagnostics Financial Overview
Table 8 Abbott Laboratories Company Overview
Table 9 Abbott Laboratories Financial Overview
Table 10 Siemens Healthineers Company Overview
Table 11 Siemens Healthineers Financial Overview
Table 12 Danaher Corporation Company Overview
Table 13 Danaher Corporation Financial Overview
Table 14 Thermo Fisher Scientific Company Overview
Table 15 Thermo Fisher Scientific Financial Overview
Table 16 Me Cure Healthcare Company Overview
Table 17 Me Cure Healthcare Financial Overview
Table 18 Afrigold Medicure Company Overview
Table 19 Afrigold Medicure Financial Overview
Table 20 Union Diagnostics and Clinical Service PLC Company Overview
Table 21 Union Diagnostics and Clinical Service PLC Financial Overview
Table 22 bioMérieux Company Overview
Table 23 bioMérieux Financial Overview
Table 24 Becton, Dickinson and Company - Company Overview
Table 25 Becton, Dickinson and Company Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us